Local Coverage Determination (LCD)

Special Electroencephalography

L33447

Expand All | Collapse All

Contractor Information

Contractor Name	Contract Type	Contract Number	Jurisdiction	States
Palmetto GBA	A and B MAC	10112 - MAC B	J - J	Alabama
Palmetto GBA	A and B MAC	10212 - MAC B	J - J	Georgia
Palmetto GBA	A and B MAC	10312 - MAC B	J - J	Tennessee
Palmetto GBA	A and B and HHH MAC	11202 - MAC B	J - M	South Carolina
Palmetto GBA	A and B and HHH MAC	11302 - MAC B	J - M	Virginia
Palmetto GBA	A and B and HHH MAC	11402 - MAC B	J - M	West Virginia
Palmetto GBA	A and B and HHH MAC	11502 - MAC B	J - M	North Carolina

LCD Information

Document Information

LCD ID
L33447

LCD Title
Special Electroencephalography

Proposed LCD in Comment Period
N/A

Source Proposed LCD
DL33447

Original Effective Date
For services performed on or after 10/01/2015

Revision Effective Date
For services performed on or after 09/19/2024

Revision Ending Date
N/A

Retirement Date
N/A

Notice Period Start Date
12/22/2016

Notice Period End Date
02/05/2017

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description

This LCD outlines limited coverage for this service with specific details under Coverage Indications, Limitations and/or Medical Necessity.

CMS National Coverage Policy

Title XVIII of the Social Security Act, §1862(a)(1)(A) excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member

Title XVIII of the Social Security Act, §1862(a)(7) excludes routine physical examinations

42 CFR §410.32(b)(3)(i), (ii) and (iii) states that diagnostic tests must be ordered by the physician treating the patient

42 CFR §410.32(d)(1) addresses who may furnish Medicare Part B services for covered diagnostic tests

CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 6, §20.4.4 Coverage of Outpatient Diagnostic Services Furnished on or After January 1, 2010

CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

An electroencephalogram (EEG) is a diagnostic test that measures the electrical activity of the brain (brainwaves) using highly sensitive recording equipment attached to the scalp by fine electrodes. It is used to diagnose neurological conditions.

This Local Coverage Determination (LCD) addresses EEG testing via 24-hour ambulatory recording.

Ambulatory EEG monitoring is a diagnostic procedure for patients, in whom a seizure diathesis is suspected but not defined by history, physical or resting EEG. Twenty-four hour ambulatory recorded EEGs offer the ability to record the EEG on a long-term, outpatient basis. Recorded electrical activity is analyzed by playback through an audio system and/or video monitors.

Ambulatory EEG monitoring may facilitate the differential diagnosis between seizures and syncopal attacks, sleep apnea, cardiac arrhythmias or hysterical episodes. The test may also allow the investigator to identify the epileptic nature of some episodic periods of disturbed consciousness, mild confusion, or peculiar behavior, where resting EEG is not conclusive. It may also allow an estimate of seizure frequency, which may at times help to evaluate the effectiveness of a drug and determine its appropriate dosage.

INDICATIONS:

• Inconclusive routine “resting” EEGs
• Experiencing episodic events where epilepsy is suspected but the history, examination, and routine EEG recordings do not resolve the diagnostic uncertainties
• Patients with confirmed epilepsy, who are experiencing suspected non-epileptic events or for classification of seizure type (only ictal recordings can reliably be used to classify seizure type(s)), which is important in selecting appropriate anti-epileptic drug therapy
• Differentiating between neurological, cardiac, and psychiatric related problems
• Localizing seizure focus for enhanced patient management
• Identifying and medicating absence seizures
• For suspected seizures of sleep disturbances
• Seizures which are precipitated by naturally occurring cyclic events or environmental stimuli which are not reproducible in the hospital or clinic setting

Ambulatory monitoring; however, is not necessary to evaluate most seizures, which are usually readily diagnosed by routine EEG studies and history. Medicare anticipates that many of these outpatient studies will not provide the diagnosis within the first 24 hours but expects that 48 hours of monitoring will be diagnostic in most circumstances. Ambulatory monitoring beyond 48 hours frequently produces poor data in the period after 48 hours, as electrode contact may no longer be optimal after 48 hours. Occasionally, patients may require an additional 48-hour monitoring period to establish a diagnosis, which is usually performed at a later date. Medical necessity must be documented for review in these circumstances. This 48-hour limitation does not apply to the inpatient setting where patients are frequently withdrawn from their anti-epileptic regimens, and where precise pre-surgical localization of epileptic foci is often conducted.

It is anticipated that once the diagnosis has been established, this study will not be repeated for the same diagnosis, nor will it be used in the monitoring of a therapeutic regimen. Again, this expectation will not be applied to patients readmitted for inpatient care of their seizure disorder.

LIMITATIONS (NON-COVERED INDICATIONS):

• Study of neonates or unattended, non-cooperative patients
• Localization of seizure focus or foci when the seizure symptoms and/or other EEG recordings indicate the presence of bilateral foci or rapid generalization

Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes

Changes	Fields Changed
	N/A

Associated Information

Sources of Information

Bibliography

Open Meetings

Contractor Advisory Committee (CAC) Meetings

MAC Meeting Information URLs

Proposed LCD Posting Date

Comment Period Start Date

Comment Period End Date

Reason for Proposed LCD

Requestor Name	Requestor Letter
	View Letter

Requestor Information

Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code	Description
Please accept the License to see the codes.

Revenue Codes

Code	Description
Please accept the License to see the codes.

ICD-10-CM Codes that Support Medical Necessity

ICD-10-CM Codes that DO NOT Support Medical Necessity

Additional ICD-10 Information

General Information

Associated Information

Documentation Requirements

Documentation supporting the medical necessity should be legible, maintained in the patient's medical record and made available to the A/B MAC upon request.

Monitoring beyond 48 hours must be supported by written documentation for each additional 24 hours of monitoring and be made available to Medicare upon request.

Utilization Guidelines

Medicare would not expect to see more than 3 services (3 of a single or 3 of any combination of services) billed in most circumstances within a 1-year period.

It is anticipated that once the diagnosis has been established, this study will not be repeated for the same diagnosis, nor will it be used in the monitoring of a therapeutic regimen. As stated above, this expectation will not be applied to patients readmitted for inpatient care of their seizure disorder.

Sources of Information

N/A

Bibliography

Chapell R, Reston J, Snyder D, et al. Management of treatment-resistant epilepsy. Evid Rep Technol Assess (Summ). 2003;(77):1-8.

Hirsch LJ, Brenner RP, Drislane FW, et al. The ACNS subcommittee on research terminology for continuous EEG monitoring: Proposed standardized terminology for rhythmic and periodic EEG patterns encountered in critically ill patients. J Clin Neurophysiol. 2005;22(2):128-135.

Ross SD, Estok R, Chopra S, French J. Management of newly diagnosed patients with epilepsy: A systematic review of the literature. Evid Rep Technol Assess (Summ). 2001;(39):1-3.

Valente KD, Freitas A, Fiore LA, et al. The diagnostic role of short duration outpatient video-EEG monitoring in children. Pediatr Neurol. 2003;28(4):285-291.

Revision History Information

Revision History Date	Revision History Number	Revision History Explanation	Reasons for Change
09/19/2024	R17	Under *CMS National Coverage Policy* removed the regulation “42 CFR §410.28(a) and (e) addresses Part B payment for diagnostic services” and placed it in the related Billing and Coding: Special Electroencephalography A56771 article. Deleted the regulation “CMS Internet-Only Manuals, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 2, §160.22 Ambulatory EEG Monitoring” as it has been retired.	Provider Education/Guidance
03/16/2023	R16	Under *CMS National Coverage Policy* corrected the following regulations: 42 CFR from §410.28(a)(e) to §410.28(a) and (e), 42 CFR from §410.32(a)(3)(i)(ii) and (iii) to 42 CFR from §410.32(b)(3)(i), (ii) and (iii) and 42 CFR from §410.32(d)(2) to §410.32(d)(1) and updated section headings. Under *Bibliography* changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation and typographical errors were corrected throughout the LCD.	Provider Education/Guidance Typographical Error
03/11/2021	R15	Under *CMS National Coverage Policy* added regulations 42 CFR §410.28(a)(e), 42 CFR §410.32(a)(3)(i)(ii) and (iii), CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80, CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 6, §20.4.4 and CMS Internet-Only Manuals, Pub. 100-03, Medicare National Coverage Determinations, Chapter 1, Part 2, §160.22. Under *Bibliography* changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation and typographical errors were corrected throughout the LCD. At this time 21^stCentury Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.	Provider Education/Guidance
10/24/2019	R14	This LCD is being revised in order to adhere to CMS requirements per chapter 13, section 13.5.1 of the Program Integrity Manual, to remove all coding from LCDs. There has been no change in coverage with this LCD revision. Regulations regarding billing and coding were removed from the *CMS National Coverage Policy* section of this LCD and placed in the related Billing and Coding: Special Electroencephalography A56771 article. Formatting, punctuation and typographical errors were corrected throughout the LCD. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.	Provider Education/Guidance
08/01/2019	R13	Under Coverage Indications, Limitations and/or Medical Necessity the verbiage “Ambulatory EEG should always be preceded by a routine EEG. A routine EEG is described by Current Procedural Terminology (CPT) codes 95812, 95813, 95816, 95819, 95822 or 95827 and refers to a routine EEG recording of less than a 24 hour continuous duration” has been removed. All coding located in the *Coding Information* section has been moved into the related Billing and Coding: Special Electroencephalography A56771 article and removed from the LCD. Under Associated Information Documentation Requirements the verbiage “A routine “resting” EEG (as described by CPT codes 95812, 95813, 95816, 95819, 95822 or 95827) must be performed prior to performing an ambulatory continuous EEG (CPT code 95953). A claim for the routine EEG must have been submitted to Medicare with a DOS within 1 year of the DOS of the ambulatory EEG” has been removed. Under *Bibliography* changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation and typographical errors were corrected throughout the LCD. At this time 21^stCentury Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.	Provider Education/Guidance
05/31/2018	R12	Under *Coverage Indications, Limitations and/or Medical Necessity* second paragraph added the verbiage “Local Coverage Determination” in front of the acronym “LCD” and in the third paragraph added the verbiage “Current Procedural Terminology” in front of the acronym “CPT”. Under CPT/HCPCS Codes added the verbiage “date of service” in front of the acronym “DOS”. Under *Bibliography* changes were made to citations to reflect AMA citation guidelines. Typographical and punctuation errors were corrected throughout the policy. At this time 21^stCentury Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.	Provider Education/Guidance Public Education/Guidance
02/26/2018	R11	The Jurisdiction "J" Part B Contracts for Alabama (10112), Georgia (10212) and Tennessee (10312) are now being serviced by Palmetto GBA. The notice period for this LCD begins on 12/14/17 and ends on 02/25/18. Effective 02/26/18, these three contract numbers are being added to this LCD. No coverage, coding or other substantive changes (beyond the addition of the 3 Part B contract numbers) have been completed in this revision.	Change in Affiliated Contract Numbers
10/01/2017	R10	Under *ICD-10 Codes that Support Medical Necessity* deleted ICD-10 codes S06.1X7S and S06.1X8S. These revisions are due to the 2017 Annual ICD-10 Updates. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.	Provider Education/Guidance Revisions Due To ICD-10-CM Code Changes
06/01/2017	R9	Under *Sources of Information and Basis for Decision -* updated titles to sources listed.	Provider Education/Guidance Typographical Error
02/06/2017	R8	No comments were received from the provider community; therefore, no revisions were made.	Provider Education/Guidance
10/01/2016	R7	Under *Coverage Indications, Limitations and/or Medical Necessity* removed cassette and amplifier and the sentence referring to electrodes for at least four (4) recording channels. Under *ICD-10 Codes That Support Medical Necessity* added ICD-10 codes A92.5 and I60.2 and deleted I60.21 and I60.22. This revision is due to the Annual ICD-10 Code Update and becomes effective 10/1/16.	Provider Education/Guidance Revisions Due To ICD-10-CM Code Changes
09/26/2016	R6	Under *CPT/HCPCS Codes Group 1: Codes* deleted 95812, 95813, 95816, 95819, 95822 and 95827.	Provider Education/Guidance Revisions Due To CPT/HCPCS Code Changes
07/25/2016	R5	Under *Coverage Indications, Limitations and/or Medical Necessity* removed "resting" from the description of a baseline EEG, added psychiatric related problems, removed adjusting anti epileptic medication levels, changed the time frame for ambulatory EEGs and added that the study will not be repeated for the same diagnosis. Under *Associated Information- Documentation Requirements* removed CPT codes 95950 and 95951, "resting", and changed 72 hours to 48 hours. Under *Associated Information- Utilization Guidelinesadded that the study will not be repeated for the same diagnosis. Under CPT/HCPCS Codes Group 1: Paragraph* removed CPT codes 95950 and 95951 and "resting". Under *CPT/HCPCS Codes Group 1: Codes* removed CPT codes 95950 and 95951.	Provider Education/Guidance Revisions Due To CPT/HCPCS Code Changes
02/04/2016	R4	Under *Coverage Indications, Limitations and/or Medical Necessity* deleted CPT code 95951 from the second sentence of the first paragraph as the code was inadvertently added to the LCD. Palmetto GBA plans to allow for a comment and notice period prior to the inclusion of CPT code 95951 in the first paragraph under *Coverage Indications, Limitations and/or Medical Necessity* .	Provider Education/Guidance Other
01/28/2016	R3	Under Coverage Indications, Limitations and/or Medical Necessity added 95951 to the Ambulatory EEG requirements of the first paragraph.	Provider Education/Guidance Public Education/Guidance Typographical Error
10/01/2015	R2	Under ICD-10 Codes that Support Medical Necessity changed reference to ICD-9 to ICD-10. Under ICD-10 Codes that Support Medical Necessity added the following codes: A17.82, A39.81, A42.82, A50.42, A52.14, A83.0, A83.1, A83.2, A83.3, A83.4, A83.5, A83.8, A83.9, A84.0, A84.1, A84.8, A84.9, A85.0, A85.1, A85.2, A85.8, A92.2, A92.31, B01.11, B02.0, B05.0, B06.01, B10.01, B10.09, B26.2, B94.1, R40.20, G04.00, G04.01, G04.02, G04.30, G04.31, G04.81, G04.90 G05.3, G92, G93.5, G93.6, H55.00, I60.01, I60.02, I60.11, I60.12, I60.21, I60.22, I60.31, I60.32, I60.4, I60.51, I60.52, I60.6, I60.8 I60.9, I61.0, I61.1, I61.2, I61.3, I61.4, I61.5, I61.6, I61.8, I62.9, I67.1, R00.0, R06.81, R25.1, R25.1, R25.2, R25.3, R25.8, R25.8 R25.9, R29.90, R40.0, R40.1, R40.2110, R40.2111, R40.2112, R40.2113, R40.2114, R40.2120, R40.2121, R40.2122, R40.2123, R40.2124, R40.2210, R40.2211, R40.2212, R40.2213, R40.2214, R40.2220, R40.2221, R40.2222, R40.2223, R40.2224, R40.2310, R40.2311, R40.2312, R40.2313, R40.2314, R40.2320, R40.2321, R40.2322, R40.2323, R40.2324, R40.2340, R40.2341, R40.2342, R40.2343, R40.2344, R40.2350, R40.2351, R40.2352, R40.2353, R40.2354, R40.2361, R40.2362, R40.2363, R40.2364, R41.0, R41.82, R45.1, R47.01, R56.9, S06.1X0A, S06.1X0D, S06.1X0S, S06.1X1A, S06.1X1D, S06.1X1S, S06.1X2A, S06.1X2D, S06.1X2S, S06.1X3A, S06.1X3D, S06.1X3S, S06.1X4A, S06.1X4D, S06.1X4S, S06.1X5A, S06.1X5D, S06.1X5S, S06.1X6A, S06.1X6D, S06.1X6S, S06.1X7A, S06.1X7D, S06.1X7S, S06.1X8A, S06.1X8D, S06.1X8S, S06.1X9A, S06.1X9D, S06.1X9S, S06.890A, S06.890D, S06.890S, S06.891A, S06.891D, S06.891S, S06.892A, S06.892D, S06.892S, S06.893A, S06.893D, S06.893S, S06.894A, S06.894D ,S06.894S, S06.895A, S06.895D, S06.895S, S06.896A, S06.896D, S06.896S	Reconsideration Request Other (Annual Validation)
10/01/2015	R1	Under *CMS National Coverage Policy,* corrected Pub. 100-02, Ch. 15, Section 231 to Section 80, requirements for diagnostic x-ray, diagnostic laboratory and other diagnostic tests. Added CMS Internet-Only Manuals, Pub. 100-03, Medicare National Coverage Determinations, Ch. 1, Part 2, Section 160.22, ambulatory EEG monitoring. Under *Sources of Information and Basis for Decision* removed bibliography Cascino, G.D. “Video-EEG Monitoring in Adults,” Epilepsia. 2002; 43 Suppl. 3: pp. 80-93, as this article was not obtainable.	Provider Education/Guidance Typographical Error

Associated Documents

Attachments
N/A

Updated On	Effective Dates	Status
09/10/2024	09/19/2024 - N/A	Currently in Effect	You are here
03/07/2023	03/16/2023 - 09/18/2024	Superseded	View
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

Special Electroencephalography
EEG

Read the LCD Disclaimer

License Agreements
American Medical Association Current Procedural Terminology
American Dental Association Current Dental Terminology
American Hospital Association NUBC UB-04

Please review the licensing information below and indicate your agreement and acceptance.

License for Use of Current Procedural Terminology (CPT)

End User Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the American Medical Association (AMA).

You, your employees, and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza, 330 Wabash Ave., Suite 39300, Chicago, IL 60611-5885. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt http://www.ama-assn.org/go/cpt.

Applicable FARS\DFARS Restrictions Apply to Government Use.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, AMA Plaza, 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of FAR 52.227-14 (December 2007) and/or subject to the restricted rights provisions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS disclaims responsibility for any liability attributable to end user use of the CPT. CMS will not be liable for any claims attributable to any errors, omissions, or other inaccuracies in the information or material contained on this page. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

License For Use of Current Dental Terminology (CDT^TM)

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood, and agreed to all terms and conditions set forth in this agreement.

If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen.

If you are acting on behalf of an organization, you represent that you are authorized to act on behalf of such organization and that your acceptance of the terms of this agreement creates a legally enforceable obligation of the organization. As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting.

Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. License to use CDT for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association web site, http://www.ADA.org/ http://www.ADA.org/.

Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use.

Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license.

ADA DISCLAIMER OF WARRANTIES AND LIABILITIES

CDT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values, or related listings are included in CDT. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for software, including any CDT and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.

CMS DISCLAIMER

The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT should be addressed to the ADA. End Users do not act for or on behalf of the CMS. CMS disclaims responsibility for any liability attributable to end user use of the CDT. CMS will not be liable for any claims attributable to any errors, omissions, or other inaccuracies in the information or material covered by this license. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I Accept". If you do not agree to the terms and conditions, you may not access or use software. Instead, you must click below on the button labeled "I Do Not Accept" and exit from this computer screen.

License For Use of National Uniform Billing Committee (NUBC) UB-04

These materials contain NUBC Official UB-04 Specifications (UB-04 Data), which is copyrighted by the American Hospital Association (AHA).

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN. IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use UB-04 Data only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of UB-04 Data is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this Agreement. You acknowledge that the AHA holds all copyright, trademark, and other rights in UB-04 Data. You shall not remove, alter, or obscure any AHA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including, by way of illustration and not by way of limitation, making copies of UB-04 Data for resale and/or license, transferring copies of UB-04 Data to any party not bound by this agreement, creating any modified or derivative work of UB-04 Data, or making any commercial use of UB-04 Data. License to use UB-04 Data for any use not authorized herein must be obtained through the American Hospital Association, 155 N. Wacker Drive, Suite 400, Chicago, Illinois, 60606. Applications are available at the NUBC website, http://www.nubc.org/ http://www.nubc.org/.
The UB-04 Data included in this product is commercial technical data and/or computer databases and/or commercial computer software and/or commercial computer software documentation, as applicable, which was developed exclusively at private expense by the American Hospital Association, 155 N. Wacker Drive, Suite 400, Chicago, Illinois 60606. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.
AHA DISCLAIMER OF WARRANTIES AND LIABILITIES. UB-04 Data is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. The sole responsibility for the software, including any UB-04 Data and other content contained therein, is with the Medicare/Medicaid Contractor or the CMS; and no endorsement by the AHA is intended or implied. The AHA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The AHA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the AHA, the copyright holder. Any questions pertaining to the license or use of the UB-04 Data should be addressed to the AHA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE UB-04 DATA. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

Submit Feedback/Ask a Question

Special Electroencephalography

Document Note

Note History

Contractor Information

LCD Information

Document Information

Issue

CMS National Coverage Policy

Coverage Guidance

Proposed Process Information

Coding Information

Bill Type Codes

Please accept the License to see the codes.

Revenue Codes

Please accept the License to see the codes.

CPT/HCPCS Codes

Please accept the License to see the codes.

ICD-10-CM Codes that Support Medical Necessity

Group 1

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Additional ICD-10 Information

General Information

Revision History Information

Associated Documents

Keywords

Page Help for LCD - Special Electroencephalography (L33447)

Introduction

More information

Tracking Sheet

Printing a Document to PDF

Get email updates

CMS & HHS WEBSITES

HELPFUL LINKS

RSS FEEDS